Publicly Traded Cannabis Stock News

Cannabis Software Provider Whaxy to Merge with MassRoots

MassRoots Enters into Definitive Agreement to Acquire Whaxy in Cash and Stock Deal DENVER, Dec. 15, 2016 /PRNewswire/ — MassRoots, Inc. (OTC: MSRT), one of the leading technology platforms...
- December 15th, 2016 at 4:37 pm

Canopy Growth Statement on Cannabis Task Force Report

SMITHS FALLS, ON, Dec. 13, 2016 /CNW/ – After a preliminary review of the findings of the special Task Force which today released recommendations on the regulation of recreational...
- December 13th, 2016 at 3:11 pm

OrganiGram Reports FY16 Sales of $6.1mm

OrganiGram Reports Financial Results and Summary Update MONCTON, NEW BRUNSWICK–(Marketwired – Dec. 13, 2016) – OrganiGram Holdings Inc. (TSXV: OGI) (OTC: OGRMF) (the “Company”) announced the financial results for...
- December 13th, 2016 at 9:26 am

Emblem to Begin Trading on the TSX Venture

Emblem Corp. Goes Public under Symbol EMC.V TORONTO, ONTARIO–(Marketwired – Dec. 8, 2016) – After much anticipation from the North American investment community, Emblem Corp. (TSXV: EMC) is set...
- December 8th, 2016 at 3:02 pm

Aurora Cannabis CEO Projects Profitability at Hand

Aurora Cannabis (TSXV: ACB) (OTC: ACBFF) CEO Terry Booth was interviewed Friday by Andrew Bell of BNN, who began with a question about the company’s financials.  Booth stated that...
- December 6th, 2016 at 7:39 pm

iAnthus Acquires Assets of Organix in Breckenridge, Colorado

iAnthus Closes Its First Cannabis-Related Asset Acquisition in Colorado TORONTO, ON and NEW YORK, NY — (Marketwired) — 12/05/16 — iAnthus Capital Holdings, Inc., (CSE: IAN) (OTC: ITHUF) (“Company”), announced...
- December 5th, 2016 at 9:29 pm

GW Pharma Ends FY16 with $483mm in Cash

GW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2016 Financial Results and Operational Progress – Three Positive Phase 3 Epidiolex clinical trials reported in 2016 – – NDA submission...
- December 5th, 2016 at 7:52 am

GW Pharma Progresses Towards Epidiolex FDA Submission

GW Announces New Epidiolex® (CBD) Positive Phase 3 Data in Dravet Syndrome and Lennox-Gastaut Syndrome – Posters Presented at American Epilepsy Society Annual Meeting – – New data includes...
- December 5th, 2016 at 7:39 am

Canopy Growth Forms Cannabis Research Incubator

Canopy Growth (TSX: CGC) (OTC: TWMJF) unveiled a new initiative today, Canopy Health Innovations (CHI), a cannabis research incubator that it formed in August. CHI will conduct exploratory studies...
- December 2nd, 2016 at 12:09 pm

First Publicly Traded Cannabis REIT IIPR Prices IPO

Innovative Industrial Properties Prices Initial Public Offering SAN DIEGO, Dec 01, 2016 (BUSINESS WIRE) — Innovative Industrial Properties, Inc. (the “Company”) (NYSE: IIPR) announced today the pricing of its...
- December 1st, 2016 at 7:41 am

Emblem to Supply Lift-Branded Cannabis

Emblem Corp. Signs Licensing Deal With Canada’s Leading Cannabis Platform Lift Co. TORONTO, ON–(Marketwired – November 30, 2016) – Lift Cannabis Co Ltd (“Lift”) announced today that it has...
- November 30th, 2016 at 2:16 pm